Isoflavones

Global Isoflavones Market to Reach US$2.1 Billion by 2030

The global market for Isoflavones estimated at US$1.5 Billion in the year 2023, is expected to reach US$2.1 Billion by 2030, growing at a CAGR of 4.9% over the analysis period 2023-2030. Soybeans, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$1.7 Billion by the end of the analysis period. Growth in the Other Types segment is estimated at 4.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$396.2 Million While China is Forecast to Grow at 7.8% CAGR

The Isoflavones market in the U.S. is estimated at US$396.2 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$478.4 Million by the year 2030 trailing a CAGR of 7.8% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.6% and 3.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.5% CAGR.

Global Isoflavones Market - Key Trends and Drivers Summarized

Why Are Isoflavones Gaining Popularity in the Nutraceutical and Pharmaceutical Sectors?

Isoflavones, a group of naturally occurring compounds found in soybeans and other plants, are gaining traction in the nutraceutical and pharmaceutical industries due to their health benefits. Known for their antioxidant, anti-inflammatory, and estrogen-like properties, isoflavones are commonly used in dietary supplements to promote heart health, alleviate menopausal symptoms, and reduce the risk of osteoporosis. Isoflavones are also being studied for their potential role in cancer prevention and treatment, particularly for hormone-related cancers such as breast and prostate cancer. As consumers become more health-conscious, the demand for plant-based supplements containing isoflavones is on the rise, driving growth in the nutraceutical market.

What Technological Innovations Are Supporting the Isoflavones Market?

Advancements in extraction and formulation technologies are significantly enhancing the quality and bioavailability of isoflavone products. Supercritical fluid extraction and other green extraction techniques are being employed to obtain high-purity isoflavones from soybeans and other plant sources without the use of harmful solvents. Furthermore, encapsulation technologies, such as liposomes and nanocarriers, are improving the absorption and stability of isoflavones in dietary supplements and pharmaceuticals. These innovations are making isoflavones more effective and accessible to a wider range of consumers, boosting their application in functional foods, dietary supplements, and pharmaceuticals.

How Do Market Segments Define the Growth of Isoflavones?

Sources include soybeans, red clover, and other plants, with soy-derived isoflavones dominating the market due to their higher concentration and widespread use in dietary supplements. Applications range from nutraceuticals and pharmaceuticals to cosmetics and functional foods, with nutraceuticals representing the largest segment as consumers seek plant-based solutions for hormone balance and overall health. Forms include powders, capsules, and liquids, with capsules leading the market due to their convenience and ease of consumption. The market is experiencing strong growth in regions such as North America and Asia-Pacific, driven by increasing health awareness and the rising popularity of natural supplements.

What Factors Are Driving the Growth in the Isoflavones Market?

The growth in the isoflavones market is driven by several factors, including rising consumer demand for natural and plant-based supplements, increasing awareness of isoflavones` health benefits, and advancements in extraction and formulation technologies. As health-conscious consumers seek alternatives to synthetic supplements, isoflavones are emerging as a popular choice due to their natural origin and scientifically backed health benefits. Additionally, the growing prevalence of lifestyle-related diseases such as heart disease, osteoporosis, and cancer is fueling demand for isoflavones in both the nutraceutical and pharmaceutical sectors. Technological advancements that improve the bioavailability and efficacy of isoflavone products are further supporting market growth.

Select Competitors (Total 36 Featured) -

• ADM
• Avestia Pharma
• BASF
• Bio-Gen Extracts Pvt. Ltd
• Biomax
• Cargill
• DSM
• Futureceuticals Inc.
• Herbo Nutra
• International Flavors and Fragrances
• Lactonova
• Nexira Inc.
• Nutra Green Biotechnology
• Nutrascience Labs
• Shaanxi Hongda Phytochemistry Co Ltd
• Shanghai Freemen
• Sikko Industries Ltd.
• SK Bioland
• Tradichem S.L
• Xena Bio Herbals Pvt Ltd.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.